🎉 Wishing our readers, advertisers and collaborators a purposeful and prosperous 2026. Thank you for being part of our journey as we continue to inform, inspire and build impact together in the year ahead. 🎉 🎉 Wishing our readers, advertisers and collaborators a purposeful and prosperous 2026. Thank you for being part of our journey as we continue to inform, inspire and build impact together in the year ahead. 🎉
U.S. FDA approves Janssen’s TREMFYA for the treatment of moderate to severe plaque psoriasis

Janssen Biotech, Inc. has announced that the U.S. Food and Drug Administration (FDA) approved TREMFYA (guselkumab) for t...

July 17, 2017 | Monday | News
Kolon Life Science wins license for gene therapy drug

South Korea based Kolon Life Science has won a license to sell the nation’s first gene therapy drug for osteoarthr...

July 17, 2017 | Monday | News
Exscientia inks €37m contract with GSK

GlaxoSmithKline has secured access to Ex Scientia Ltd (Exscientia)’s artificial intelligence (AI)-driven drug...

July 3, 2017 | Monday | News
Promethazine by Strides Shasun approved by USFDA

Strides Shasun has recently received an approval from the United States Food & Drug Administration (USFDA) for Prome...

July 3, 2017 | Monday | News
Amgen’s uncontrolled LDL cholesterol lowering drug available in Singapore

Singapore – Amgen, a US based biotechnology company, announced the availability of Repatha(evolocumab), the first ...

July 3, 2017 | Monday | News
Strategic alliance between Alma Bio Therapeutics and Delphi Genetics on Plasmid DNA drugs

Alma Bio Therapeutics SAS (Alma) and Delphi Genetics SA recently announced that they are taking their strategic alliance...

June 27, 2017 | Tuesday | News
J&J’s type 2 diabetes drug INVOKANA significantly reduces major heart complications in CANVAS program

Singapore – Results from the landmark CANVAS Program showed INVOKANA (canagliflozin) significantly reduc...

June 27, 2017 | Tuesday | News
BioAuxilium completes development of its 100th TR-FRET assay kit

Canada based company BioAuxilium specialised in the development of custom TR-FRET assay kit recently announced the succe...

June 23, 2017 | Friday | News
Major advancement in cell-based influenza vaccine technology by Seqirus

Innovator in influenza vaccines and pandemic preparedness Seqirus recently announced the next major advancement in the u...

June 23, 2017 | Friday | News
New patent issuance for Zyga's SImmetry Sacroiliac Joint Fusion System

Singapore - Zyga Technology, Inc., a US based medical device company announced the issuance of a new US Patent represent...

June 22, 2017 | Thursday | News
New antibody for effective blood cancer treatment using two-pronged approach

Singapore- Researchers have developed a two-pronged approach to blood cancer treatment: 1) attacking cancer cells direct...

June 22, 2017 | Thursday | News
Sunless tan now a reality!

Scientists have answered the woes of spending hours and hours on sunbeds to achieve the perfect bronzed tone. Better yet...

June 21, 2017 | Wednesday | News
A type-2 diabetes drug found to reduce heart and kidney risk

Researchers have claimed that a drug that lowers blood sugar levels for people with Type 2 diabetes may also significant...

June 21, 2017 | Wednesday | News
Enzychem Lifesciences Announces Global Phase 2 Trial Inititation of EC-18 in Patients with Chemotherapy Induced Neutropenia(CIN)

Enzychem Lifesciences, Corp., a Korea based life sciences company announced the initiation of the dose-escalation stage ...

June 20, 2017 | Tuesday | News
NanoBio And Porton Biopharma receive approval to advance Anthrax Vaccine

NanoBio Corporation, a US based biopharmaceutical company focused on developing and commercializing vaccines and anti-in...

June 20, 2017 | Tuesday | News
New, long-acting insulin therapy demonstrates Cardiovascular Safety

Singapore - During a symposium, titled "Cardiovascular Safety of Insulin Degludec vs. Insulin Glargine in Patients with ...

June 13, 2017 | Tuesday | News
A translational research collaboration

The Scripps Research Institute (TSRI) and ShangPharma Innovation, Inc. (SPII) announced a strategic collaboration to acc...

June 9, 2017 | Friday | News
BD Receives FDA 510(K) Clearance for Molecular Test of Acute Gastroenteritis.

Singapore - BD (Becton, Dickinson and Company), a global medical technology company, announced 510 (k) clearance from th...

June 5, 2017 | Monday | News